# 2026-13479: U.S. Offers New HTLV-1 Vaccine Technology for Licensing

2026-13479, Government Owned Invention Available for License: Chimeric VLP Vaccines To Prevent HTLV-1 Infection, is a Federal Register notice from Health and Human Services Department, National Institutes of Health published 2026-07-02; PRIA reads it as touching household money (as of 2026-07-09).

- Canonical: https://policyrisk.com/federal-register/2026-13479
- As of: 2026-07-09
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-13479
- Title: Government Owned Invention Available for License: Chimeric VLP Vaccines To Prevent HTLV-1 Infection
- Type: Notice
- Agencies: Health and Human Services Department; National Institutes of Health
- Citation: 91 FR 40547
- Published: 2026-07-02
- Effective: unknown
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-07-09

## In one line

U.S. Offers New HTLV-1 Vaccine Technology for Licensing

## Summary

The National Cancer Institute has created a new vaccine to stop HTLV-1, a virus that can cause serious diseases like leukemia. Right now, no vaccine exists, so this invention could protect millions, especially in underserved areas. They’re looking for partners to help develop and license this promising vaccine, which could save lives and reduce healthcare costs in the near future.

## Abstract

The National Cancer Institute (NCI) seeks research co- development partners and/or licensees for Chimeric VLP Vaccines to Prevent HTLV-1 Infection.

## Effects PRIA read

- Government Vaccine Licensing Opportunity: benefit, medium. The National Cancer Institute is seeking research co-development partners and/or licensees for a nucleic acid-based chimeric virus-like particle (VLP) vaccine to prevent HTLV-1 infection (NIH Reference Number E-126-2022). The technology is at the preclinical (in vivo validation) stage and is availa…
- Potential HTLV-1 Vaccine Could Cut Disease Burden: benefit, high. The invention is a preventive nucleic acid-based vaccine that produces HTLV-1 virus-like particles and is intended to protect against HTLV-1 infection, which is linked to adult T-cell leukemia/lymphoma (ATLL) and HAM/TSP. The notice states this vaccine could protect millions—particularly in underse…

## Related documents

- [2026-22871](https://policyrisk.com/federal-register/2026-22871): Center for Scientific Review; Notice of Closed Meetings, 2026-11-10
- [2026-22550](https://policyrisk.com/federal-register/2026-22550): Center for Scientific Review; Notice of Closed Meetings, 2026-11-05
- [2026-22558](https://policyrisk.com/federal-register/2026-22558): Center for Scientific Review; Notice of Closed Meetings, 2026-11-05
- [2026-22339](https://policyrisk.com/federal-register/2026-22339): Prospective Grant of Exclusive Patent License: Catheter-Based Intramyocardial Ablation for Treating Ventricular Arrhythmia in a Human, 2026-11-02
- [2026-22196](https://policyrisk.com/federal-register/2026-22196): National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting, 2026-10-30
- [2026-22111](https://policyrisk.com/federal-register/2026-22111): Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting, 2026-10-29

## Sources
- [2026-13479 on federalregister.gov](https://www.federalregister.gov/documents/2026/07/02/2026-13479/government-owned-invention-available-for-license-chimeric-vlp-vaccines-to-prevent-htlv-1-infection)
- [2026-13479 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-07-02/pdf/2026-13479.pdf)

## Related
- [Previous: 2026-13478, Agency Information Collection Activities: Request for Comments; Revision of Cur…](https://policyrisk.com/federal-register/2026-13478)
- [Next: 2026-13480, Government Owned Invention Available for License: A Conserved Viral Peptide for…](https://policyrisk.com/federal-register/2026-13480)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-13479 (as of 2026-07-09).
